跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 36,077 条关于
“Hanmi Pharmaceutical Company Limited”
全部
36,077
临床试验
4,159
药物
1,777
机构
4,391
资讯
25,750
去年
Hansoh Pharma's HS-20093 Granted Breakthrough Therapy Designation for Lung Cancer
去年
Hansoh Pharma's Aumolertinib Plus Chemotherapy Shows Positive Phase III Results in EGFR-Mutated NSCLC
去年
Hansoh Pharma's HS-20093 ADC Granted Breakthrough Therapy Designation for ES-SCLC
去年
Hanmi's BH3120 Shows Promise in Phase 1 Trials for Advanced Solid Tumors
去年
Hanmi's BH3120 Shows Promise in Early Clinical Trials for Advanced Solid Tumors
去年
Hanmi Pharmaceutical Advances BH3120 Immunotherapy Trials Targeting Solid Tumors
12天前
Hanmi Pharmaceutical to Fully Deploy AI Across Quality Assurance, Training on 4,000 SOPs
去年
Hanmi Pharmaceutical Fast-Tracks Efeglenatide Launch for Obesity Treatment
去年
Gastric Cancer Pipeline Shows Robust Growth with 220+ Therapies in Development Across 200+ Companies
去年
Hanmi Pharmaceutical to Present Phase 1 Results of Next-Generation Obesity Drugs at ADA 2025
第 1 页，共 2575 页
上一页
下一页
